Onc.Ai Raises $25 Million Series A Financing Co-Led By Massmutual And Action Potential Venture Capital
Onc.Ai Raises $25 Million Series A Financing Co-Led By Massmutual And Action Potential Venture Capital
01/05/23, 10:05 AM
Location
san carlosMoney raised
$25 million
Round Type
series a
Investors
Kd T Ventures, Digitalis Ventures, Blue Venture Fund, Life Extension Ventures, Action Potential Venture Capital
Onc.AI, a medical technology company developing a novel digital clinical management solution focused on immuno-oncology, announced today it has closed a $25 million Series A financing co-led by MassMutual and Action Potential Venture Capital (a GSK venture fund). Also participating were Life Extension Ventures and all existing investors including Blue Venture Fund, Accomplice, Digitalis Ventures, and KdT Ventures.
Company Info
Location
san carlos, california, united states
Additional Info
Onc.AI is a privately held medical technology company developing a digital clinical management platform focused on immuno-oncology. Onc.AI is backed by premier investment firms The Blue Venture Fund, MassMutual Alternative Investments, Action Potential Venture Capital, Accomplice, Digitalis Ventures, Life Extension Ventures, KdT Ventures as well as prominent individual investors who are leaders in Enterprise SaaS, AI/drug-discovery, precision/medical oncology, and radiology. For more information, visit http://onc.ai